Guardant Health Files 2023 10-K, Details Financials

TL;DR

**Guardant Health just dropped its 2023 10-K, giving us the full financial picture for the year ending December 31st!**

AI Summary

Guardant Health, Inc. filed its 10-K on February 22, 2024, for the fiscal year ending December 31, 2023. The company, a medical laboratory service provider based in Palo Alto, CA, reported its financial performance for 2023, 2022, and 2021, with a focus on its common stock, additional paid-in capital, and retained earnings. The filing also references accounting standard updates, specifically ASU 2020-06, impacting its financial reporting.

Why It Matters

This filing provides a comprehensive look into Guardant Health's financial health and operational performance, crucial for investors and stakeholders to assess its future prospects and stability in the medical diagnostics market.

Risk Assessment

Risk Level: medium — The filing details financial performance and accounting standards, which can indicate operational risks and compliance challenges, but without specific negative disclosures, it's not high risk.

Key Numbers

• 001-38683 — SEC File Number (Identifies Guardant Health's registration with the SEC)
• 109 — Public Document Count (Indicates the volume of information in the filing)
• 855-698-8887 — Business Phone (Contact information for Guardant Health)
• 2023-12-31 — Fiscal Year End (The end date of the financial reporting period)
• 0001576280 — Central Index Key (CIK) (Unique identifier for Guardant Health in SEC filings)

Key Players & Entities

• Guardant Health, Inc. (company) — Filer of the 10-K
• Palo Alto, CA (company) — Business address of Guardant Health, Inc.
• December 31, 2023 (date) — Conformed period of report end date
• February 22, 2024 (date) — Filed as of date
• ASU 2020-06 (other) — Accounting Standards Update referenced in the filing

FAQ

From the Filing

0001576280-24-000043.txt : 20240222 0001576280-24-000043.hdr.sgml : 20240222 20240222172338 ACCESSION NUMBER: 0001576280-24-000043 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 109 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 24666213 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 10-K 1 gh-20231231.htm 10-K gh-20231231 false 2023 FY 0001576280 http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent 0.0071523 P6M 4 0001576280 2023-01-01 2023-12-31 0001576280 2023-06-30 iso4217:USD 0001576280 2024-02-16 xbrli:shares 0001576280 2022-01-01 2022-12-31 0001576280 2023-12-31 0001576280 2022-12-31 iso4217:USD xbrli:shares 0001576280 2021-01-01 2021-12-31 0001576280 gh:RedeemableNoncontrollingInterestMember 2020-12-31 0001576280 us-gaap:CommonStockMember 2020-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001576280 us-gaap:RetainedEarningsMember 2020-12-31 0001576280 2020-12-31 0001576280 2020-01-01 2020-12-31 0001576280 us-gaap:AccountingStandardsUpdate202006Member us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-12-31 0001576280 us-gaap:AccountingStandardsUpdate202006Member us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-12-31 0001576280 us-gaap:AccountingStandardsUpdate202006Member srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-12-31 0001576280 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001576280 gh:RedeemableNoncontrollingInterestMember 2021-01-01 2021-12-31 0001576280 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001576280 gh:RedeemableNoncontrollingInterestMember 2021-12-31 0001576280 us-gaap:CommonStockMember 2021-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001576280 us-gaap:RetainedEarningsMember 2021-12-31 0001576280 2021-12-31 0001576280 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001576280 gh:RedeemableNoncontrollingInterestMember 2022-12-31 0001576280 us-gaap:CommonStockMember 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-12-31 0001576280 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001576280 gh:RedeemableNoncontrollingInterestMember 2023-12-31 0001576280 us-gaap:CommonStockMember 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 20